|
|
|
|
| LEADER |
02586nam a2200313 u 4500 |
| 001 |
EB001999797 |
| 003 |
EBX01000000000000001162698 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 100 |
1 |
|
|a DeHaan, Elliot
|e [author]
|
| 245 |
0 |
0 |
|a Post-exposure prophylaxis (PEP) to prevent HIV infection
|h Elektronische Ressource
|c Clinical Guidelines Program, New York State Department of Health AIDS Institute ; lead author, Elliot DeHaan ; with the Medical Care Criteria Committee
|
| 246 |
3 |
1 |
|a PEP to prevent HIV infection
|
| 260 |
|
|
|a [New York]
|b New York State Department of Health AIDS Institute
|c 2020, June 2020
|
| 300 |
|
|
|a 1 PDF file (86 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Hepatitis B / prevention & control
|
| 653 |
|
|
|a Hepatitis C / prevention & control
|
| 653 |
|
|
|a HIV Infections / prevention & control
|
| 653 |
|
|
|a Post-Exposure Prophylaxis / standards
|
| 653 |
|
|
|a Risk Assessment
|
| 710 |
2 |
|
|a Clinical Guidelines Program
|
| 710 |
2 |
|
|a New York (State)
|b AIDS Institute
|
| 710 |
2 |
|
|a New York (State)
|b AIDS Institute
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 856 |
4 |
0 |
|u http://www.ncbi.nlm.nih.gov/books/NBK562734
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a This guideline was developed by the New York State Department of Health (NYSDOH) AIDS Institute (AI) for healthcare practitioners in any medical setting (e.g., emergency department, sexual health clinic, urgent care clinic, inpatient unit primary care practice) who manage the care of individuals who request post-exposure prophylaxis (PEP) after a possible exposure to HIV. Despite the availability of prevention measures, exposures occur that pose the risk of transmission. Fortunately, with rapid initiation of PEP, infection can be blocked. Preventing new HIV infections is crucial to the success of New York State's Ending the Epidemic Initiative. HIV transmission can be prevented through use of barrier protection during sex (e.g., latex condoms), safer drug injection techniques, and adherence to universal precautions in the healthcare setting. HIV infection can also be prevented with use of antiretroviral (ARV) medications taken as pre-exposure prophylaxis (PrEP). After an exposure has occurred, HIV infection can be prevented with rapid administration of ARV medications as PEP. The first dose of PEP should be administered within 2 hours of an exposure (ideal) and no later than 72 hours after an exposure
|